Form D · Other Health Care
INNOVATIVE CLINICAL SOLUTIONS INC
New York, NY · CIK 0001433673
Offering snapshot reported Oct 29, 2009 · SEC filing
- Reported sold
- $200K Offering amount: $5.03M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Oct 27, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2009 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $240K (estimated)
- Form D file number
- 021-117543
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BEDMINSTER FINANCIAL GROUP LTD. | 39916 |
Source: Form D, filed Oct 29, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jared Nussbaum | Director, Executive, Promoter |
| Michael Schulman | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
192 Lexington Ave Suite 603
New York, NY, 10016
New York, NY, 10016